Smruthi Organics : Certificate under Regulation 74 (5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018 for the ended 31st March, 2024
Subject: Confirmation Certificate in the matter of Regulation 74(5) of Securities and Exchange Board of India (Depositories and participants) Regulations, 2018.
Dear Sir/Madam,
In reference to the above captioned regulation,we hereby confirm that the securities received from the depository participants for dematerialisation during the quarter ended 31st March,2024,
were confirmed (accepted/rejected) to the depositories by us and that securities comprised in the said certificates have been listed on the stock exchanges where the earlier issued securities are listed.
We hereby also confirm that the security certificates received for dematerialisation have been Mutilated and cancelled after due verification by the depository participant and the name of the depositories have been substituted in register of members as registered owner within 15 days.
We request you to kindly take note of the above in your records.
Smruthi Organics Ltd. published this content on
05 April 2024 and is solely responsible for the information contained therein. Distributed by
Public, unedited and unaltered, on
05 April 2024 07:00:06 UTC.
Smruthi Organics Limited is an India-based active pharmaceutical ingredients (API) manufacturer serving pharmaceutical companies. The Companyâs segments include Bulk Drugs and Drugs Intermediates and Formulation. It manufactures API products in the anti-diabetic, anti-hypertension and anti-infectives therapeutic categories. Its products include Amlodipine Besilate, Losartan Potassium, Telmisartan, Metformin HCL, S-Amlodipine Besilate, S-Amlodipine Malelate, Valsartan, Vildagliptin, Teneligliptin, Ciprofloxacin HCL, Diloxanide Furoate, Norfloxacin, Pefloxacin Mesylate, Ticagrelor, and others. It caters to both the Indian domestic as well as the rest of the world (ROW) markets, with clients spanning Asia, the Americas, and Africa. The Company has two manufacturing facilities in Solapur, India. The API facility is spread across 22-acre land.
Smruthi Organics : Certificate under Regulation 74 (5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018 for the ended 31st March, 2024